Cite
HARVARD Citation
Setton, J. et al. (n.d.). CDK12 loss leads to replication stress and sensitivity to combinations of the ATR inhibitor camonsertib (RP-3500) with PARP inhibitors. European journal of cancer. pp. S99-S100. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Setton, J. et al. (n.d.). CDK12 loss leads to replication stress and sensitivity to combinations of the ATR inhibitor camonsertib (RP-3500) with PARP inhibitors. European journal of cancer. pp. S99-S100. [Online].